These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 33439124)

  • 21. Genetic markers for methazolamide-induced Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Huang PW; Chu CY
    J Eur Acad Dermatol Venereol; 2022 Jun; 36(6):764. PubMed ID: 35536169
    [No Abstract]   [Full Text] [Related]  

  • 22. Serious Adverse Events of Oral and Topical Carbonic Anhydrase Inhibitors.
    Popovic MM; Schlenker MB; Thiruchelvam D; Redelmeier DA
    JAMA Ophthalmol; 2022 Mar; 140(3):235-242. PubMed ID: 35084437
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Absence of toxic epidermal necrolysis recurrence with pembrolizumab re-challenge in a patient with a positive lymphocyte transformation test.
    Kawada M; Nobeyama Y; Goto Y; Nakama K; Yamazaki N; Asahina A
    J Dermatol; 2020 Dec; 47(12):e424-e425. PubMed ID: 32815211
    [No Abstract]   [Full Text] [Related]  

  • 24. Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Association with Commonly Prescribed Drugs in Outpatient Care Other than Anti-Epileptic Drugs and Antibiotics: A Population-Based Case-Control Study.
    Frey N; Bodmer M; Bircher A; Jick SS; Meier CR; Spoendlin J
    Drug Saf; 2019 Jan; 42(1):55-66. PubMed ID: 30112729
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of HLA-C*01:02 with methazolamide-induced toxic epidermal necrolysis.
    Qiumei G; Zhengju C; Xuefei H; Qu C
    BMJ Case Rep; 2022 Dec; 15(12):. PubMed ID: 36572447
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis: results of an international prospective study.
    Auquier-Dunant A; Mockenhaupt M; Naldi L; Correia O; Schröder W; Roujeau JC;
    Arch Dermatol; 2002 Aug; 138(8):1019-24. PubMed ID: 12164739
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hematologic reactions to carbonic anhydrase inhibitors.
    Fraunfelder FT; Meyer SM; Bagby GC; Dreis MW
    Am J Ophthalmol; 1985 Jul; 100(1):79-81. PubMed ID: 4014383
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aplastic anemia resulting from the use of carbonic anhydrase inhibitors.
    Wisch N; Fischbein FI; Siegel R; Glass JL; Leopold I
    Am J Ophthalmol; 1973 Jan; 75(1):130-2. PubMed ID: 4684255
    [No Abstract]   [Full Text] [Related]  

  • 29. [Lamotrigine and its relationship with Stevens-Johnson syndrome and toxic epidermal necrolysis].
    Velázquez-Cárcamo EA; Rodríguez-Chávez Y; Méndez-Flores S; Domínguez-Cherit J
    Rev Med Inst Mex Seguro Soc; 2020 Apr; 58(2):202-205. PubMed ID: 34101565
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Toxic epidermal necrolysis and Stevens-Johnson syndrome: a review.
    Gerull R; Nelle M; Schaible T
    Crit Care Med; 2011 Jun; 39(6):1521-32. PubMed ID: 21358399
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stevens-Johnson syndrome associated with intravenous acetazolamide administration for evaluation of cerebrovascular reactivity. Case report.
    Ogasawara K; Tomitsuka N; Kobayashi M; Komoribayashi N; Fukuda T; Saitoh H; Inoue T; Ogawa A
    Neurol Med Chir (Tokyo); 2006 Mar; 46(3):161-3. PubMed ID: 16565588
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effectiveness, safety and tolerability of cyclosporine versus supportive treatment in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: A record-based study.
    Mohanty S; Das A; Ghosh A; Sil A; Gharami RC; Bandyopadhyay D; Das NK
    Indian J Dermatol Venereol Leprol; 2017; 83(3):312-316. PubMed ID: 28366923
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Carbonic anhydrase and control of breathing: different effects of benzolamide and methazolamide in the anaesthetized cat.
    Teppema L; Berkenbosch A; DeGoede J; Olievier C
    J Physiol; 1995 Nov; 488 ( Pt 3)(Pt 3):767-77. PubMed ID: 8576866
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Burn Center Care of Patients with Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.
    Cartotto R
    Clin Plast Surg; 2017 Jul; 44(3):583-595. PubMed ID: 28576247
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro drug causality assessment in Stevens-Johnson syndrome - alternatives for lymphocyte transformation test.
    Porebski G; Pecaric-Petkovic T; Groux-Keller M; Bosak M; Kawabata TT; Pichler WJ
    Clin Exp Allergy; 2013 Sep; 43(9):1027-37. PubMed ID: 23957338
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessing carbamazepine and oxcarbazepine-associated Stevens-Johnson syndrome/toxic epidermal necrolysis: Data mining the public version of the FDA adverse event reporting system.
    Xu C; Pan L; Zhang Y; Zhang J; Sun Q; Fang W
    Int J Clin Pract; 2021 Aug; 75(8):e14273. PubMed ID: 33908133
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Urinary calculi with methazolamide therapy.
    Ellis PP
    Doc Ophthalmol; 1973 Feb; 34(1):137-42. PubMed ID: 4706085
    [No Abstract]   [Full Text] [Related]  

  • 38. [Toxic epidermal necrolysis (syndrome Lyell) versus Stevens-Johnson syndrome].
    Jezierska-Krupa B; Hyla-Klekot L
    Pediatr Pol; 1996 Jul; 71(7):615-20. PubMed ID: 8803466
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reducing side effects of carbonic anhydrase inhibitors.
    Lichter PR
    Ophthalmology; 1981 Mar; 88(3):266-9. PubMed ID: 7231916
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comprehensive assessment of T cell receptor β repertoire in Stevens-Johnson syndrome/toxic epidermal necrolysis patients using high-throughput sequencing.
    Xiong H; Wang L; Jiang M; Chen S; Yang F; Zhu H; Zhu Q; Tang C; Qin S; Xing Q; Luo X
    Mol Immunol; 2019 Feb; 106():170-177. PubMed ID: 30623817
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.